IBOV 177,999.00 ▲ 0.47% IPSA 11,016.85 ▼ 0.13% IPC MEX 66,935.53 ▼ 0.58% MERVAL 3,291,323 ▼ 0.41% COLCAP 2,392.10 ▲ 2.12% BVL PERÚ 57,890.85 — — USD/BRL5.07▼ 0.09% USD/MXN17.33▼ 0.01% USD/CLP 930.47 — 0.00% USD/COP3,151▲ 0.93% USD/PEN3.39▼ 0.01% USD/ARS1,485— 0.00% USD/UYU40.20▲ 1.25% USD/PYG5,931▲ 1.14% USD/BOB12.10▲ 4.29% USD/DOP57.99▲ 0.24% USD/CRC448.40▲ 1.33% USD/GTQ7.62▲ 2.25% USD/HNL26.76▲ 1.53% USD/NIO 36.62 — 0.00% USD/VES744.76▼ 0.41% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.19▲ 0.37% USD/TTD6.72▲ 0.86% EUR/BRL5.85▼ 0.37% BRENT 90.12 ▲ 1.22% WTI 84.67 ▲ 1.29% IRON ORE 161.91 — — COPPER 6.47 ▲ 0.33% GOLD 4,107 ▲ 0.17% SILVER 57.79 ▼ 1.75% SOY 1,188 ▲ 0.87% CORN 464.00 ▲ 4.09% WHEAT 639.25 ▼ 3.65% COFFEE 313.55 ▼ 2.94% SUGAR 14.65 ▲ 1.52% ORANGE JUICE 153.35 ▲ 5.03% COTTON 81.20 ▲ 2.25% COCOA 5,537 ▲ 8.31% BEEF 227.25 ▼ 1.72% CATTLE 343.78 ▼ 0.78% LITHIUM 69.22 ▼ 0.85% PETR4 43.42 ▲ 1.35% VALE3 76.28 ▲ 0.25% ITUB4 42.89 ▲ 0.35% BBDC4 18.43 ▲ 0.22% ABEV3 15.99 ▲ 0.19% BBAS3 21.35 ▲ 0.76% B3SA3 15.73 ▲ 0.64% WEGE3 47.20 ▲ 0.81% PRIO3 60.85 ▲ 1.48% SUZB3 43.32 ▲ 1.38% RENT3 37.61 ▼ 1.62% AZZA3 16.42 ▲ 3.53% CSAN3 4.07 ▲ 2.01% RAIZ4 0.26 — 0.00% PCAR3 2.59 ▼ 5.47% GMAT3 4.03 ▲ 1.26% PSSA3 54.70 ▲ 0.64% CVCB3 1.31 ▲ 0.77% POSI3 3.55 ▲ 0.85% SLCE3 13.38 ▲ 0.91% NATU3 8.38 ▲ 0.60% BRKM5 5.97 ▲ 0.67% RANI3 8.11 ▲ 1.00% CSNA3 4.84 ▼ 2.22% CMIN3 5.71 ▼ 0.17% USIM5 7.36 ▼ 2.52% GGBR4 24.98 — 0.00% ENEV3 26.31 ▲ 0.61% CPFE3 46.14 ▲ 0.11% CMIG4 11.34 ▲ 0.98% EQTL3 38.66 — 0.00% LREN3 13.60 ▲ 0.59% VIVT3 32.63 — 0.00% RAIL3 14.44 ▲ 1.12% KLABIN 18.25 ▲ 1.11% RAIA DROGASIL 18.48 ▲ 1.26% RDOR3 34.64 ▲ 0.64% HAPV3 11.28 ▲ 2.45% FLRY3 17.14 ▲ 1.00% SMTO3 14.52 ▲ 0.83% UGPA3 33.05 ▲ 0.39% VBBR3 36.05 ▲ 1.18% BBSE3 41.26 ▲ 0.98% BPAC11 56.80 ▲ 0.32% CURY3 30.09 ▼ 1.02% AERI3 2.15 ▲ 0.94% VIVARA 22.18 ▲ 0.09% COMPASS 24.84 — 0.00% VAMOS 3.34 ▼ 2.34% SANB11 28.62 ▲ 13.35% ASAI3 8.50 ▲ 1.07% SBSP3 27.70 ▲ 1.06% WALMEX 50.36 ▲ 0.34% GMEXICO 208.29 ▼ 2.20% FEMSA 221.95 ▲ 1.19% CEMEX 20.54 ▼ 0.73% GFNORTE 199.64 ▼ 0.32% BIMBO 62.08 ▲ 2.26% TELEVISA 9.79 ▼ 0.91% AMX 22.00 — 0.00% GAP 376.64 ▼ 1.08% ASUR 275.62 ▼ 0.34% OMA 231.05 ▼ 0.96% KOF 187.94 ▼ 0.14% GRUMA 258.23 ▼ 4.00% KIMBER 40.19 ▼ 0.17% SQM-B 62,700 ▼ 0.93% COPEC 6,350 ▲ 0.79% BSANTANDER 80.99 ▲ 0.36% FALABELLA 6,216 ▼ 0.06% ENELAM 87.99 ▲ 0.39% CENCOSUD 1,955 ▲ 0.51% CMPC 1,055 ▲ 2.43% BANCO CHILE 193.71 ▼ 1.57% LATAM AIR 24.74 ▼ 0.64% YPF 82,900 ▲ 1.94% GGAL 7,890 ▼ 1.56% PAMPA 5,555 ▲ 0.36% TXAR 659.50 ▲ 1.77% ALUAR 977.50 ▼ 0.20% TGS 10,050 ▲ 2.45% CEPU 2,396 ▼ 0.33% MIRGOR 16,350 ▼ 1.95% COME 44.03 ▼ 1.94% LOMA NEGRA 3,620 ▼ 1.76% BYMA 296.00 ▼ 0.34% TELECOM ARG 4,408 ▲ 2.14% ECOPETROL 16.77 ▼ 1.58% BANCOLOMBIA 92.52 ▼ 1.46% GRUPO AVAL 5.28 ▲ 2.75% CREDICORP 400.58 ▼ 0.42% SOUTHERN COPPER 182.71 ▼ 1.24% BUENAVENTURA 30.28 ▼ 4.96% MERCADOLIBRE 1,878 ▼ 0.41% NUBANK 14.33 ▼ 1.10% XP 17.06 ▼ 0.81% PAGSEGURO 9.64 ▼ 2.03% STONE 11.38 ▼ 0.48% GLOBANT 36.60 ▲ 0.58% TECNOGLASS 43.44 ▼ 0.34% GAP AIRPORT 217.35 ▼ 1.02% ASUR 275.62 ▼ 0.34% OMA AIRPORT 106.90 ▼ 1.10% AMX ADR 25.37 ▲ 0.18% FEMSA ADR 127.99 ▲ 0.97% CEMEX ADR 11.82 ▼ 0.92% PETROBRAS ADR 19.40 ▲ 1.46% VALE ADR 15.06 ▲ 0.47% ITAU ADR 8.46 ▲ 0.24% SANTANDER BR 5.67 ▲ 12.28% AMBEV ADR 3.11 ▼ 0.32% CSN 0.99 ▼ 2.42% GERDAU 4.96 — 0.00% LATAM ADR 52.75 ▼ 2.21% BTC 63,011 ▲ 0.39% ETH 1,854 ▲ 0.57% SOL 72.80 ▲ 1.30% XRP 1.08 ▲ 1.84% BNB 581.85 ▲ 1.20% ADA 0.19 ▲ 9.81% DOGE 0.07 ▲ 1.49% AVAX 6.58 ▲ 6.40% LINK 8.29 ▲ 2.90% DOT 0.80 ▲ 2.24% LTC 44.64 ▲ 1.03% BCH 212.20 ▲ 2.06% TRX 0.33 ▼ 0.34% XLM 0.17 ▲ 2.04% HBAR 0.07 ▲ 1.67% NEAR 1.70 ▲ 1.52% ATOM 1.25 ▲ 2.30% AAVE 91.00 ▲ 0.53% SELIC 14.25% EMBRAER 86.89 ▲ 0.87% EMBRAER ADR 68.33 ▲ 0.32% JBS 14.02 ▼ 1.89% JBS BDR 70.70 ▼ 2.01% MBRF3 17.54 ▼ 2.34% MBRFY 3.39 ▼ 2.31% INTER 5.60 ▼ 0.71% IBOV 177,999.00 ▲ 0.47% IPSA 11,016.85 ▼ 0.13% IPC MEX 66,935.53 ▼ 0.58% MERVAL 3,291,323 ▼ 0.41% COLCAP 2,392.10 ▲ 2.12% BVL PERÚ 57,890.85 — — USD/BRL 5.07 ▼ 0.09% USD/MXN 17.33 ▼ 0.10% USD/CLP 930.47 — 0.00% USD/COP 3,151 ▼ 1.55% USD/PEN 3.39 ▼ 0.05% USD/ARS 1,485 ▼ 0.27% USD/UYU 40.20 ▲ 1.31% USD/PYG 5,931 ▲ 0.69% USD/BOB 12.10 ▲ 8.06% USD/DOP 57.99 ▲ 0.14% USD/CRC 448.40 ▲ 1.30% USD/GTQ 7.62 ▲ 2.31% USD/HNL 26.76 ▲ 0.39% USD/NIO 36.62 — 0.00% USD/VES 744.76 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.19 ▲ 0.37% USD/TTD 6.72 ▲ 0.86% EUR/BRL 5.85 ▼ 0.37% BRENT 90.12 ▲ 1.22% WTI 84.67 ▲ 1.29% IRON ORE 161.91 — — COPPER 6.47 ▲ 0.33% GOLD 4,107 ▲ 0.17% SILVER 57.79 ▼ 1.75% SOY 1,188 ▲ 0.87% CORN 464.00 ▲ 4.09% WHEAT 639.25 ▼ 3.65% COFFEE 313.55 ▼ 2.94% SUGAR 14.65 ▲ 1.52% ORANGE JUICE 153.35 ▲ 5.03% COTTON 81.20 ▲ 2.25% COCOA 5,537 ▲ 8.31% BEEF 227.25 ▼ 1.72% CATTLE 343.78 ▼ 0.78% LITHIUM 69.22 ▼ 0.85% PETR4 43.42 ▲ 1.35% VALE3 76.28 ▲ 0.25% ITUB4 42.89 ▲ 0.35% BBDC4 18.43 ▲ 0.22% ABEV3 15.99 ▲ 0.19% BBAS3 21.35 ▲ 0.76% B3SA3 15.73 ▲ 0.64% WEGE3 47.20 ▲ 0.81% PRIO3 60.85 ▲ 1.48% SUZB3 43.32 ▲ 1.38% RENT3 37.61 ▼ 1.62% AZZA3 16.42 ▲ 3.53% CSAN3 4.07 ▲ 2.01% RAIZ4 0.26 — 0.00% PCAR3 2.59 ▼ 5.47% GMAT3 4.03 ▲ 1.26% PSSA3 54.70 ▲ 0.64% CVCB3 1.31 ▲ 0.77% POSI3 3.55 ▲ 0.85% SLCE3 13.38 ▲ 0.91% NATU3 8.38 ▲ 0.60% BRKM5 5.97 ▲ 0.67% RANI3 8.11 ▲ 1.00% CSNA3 4.84 ▼ 2.22% CMIN3 5.71 ▼ 0.17% USIM5 7.36 ▼ 2.52% GGBR4 24.98 — 0.00% ENEV3 26.31 ▲ 0.61% CPFE3 46.14 ▲ 0.11% CMIG4 11.34 ▲ 0.98% EQTL3 38.66 — 0.00% LREN3 13.60 ▲ 0.59% VIVT3 32.63 — 0.00% RAIL3 14.44 ▲ 1.12% KLABIN 18.25 ▲ 1.11% RAIA DROGASIL 18.48 ▲ 1.26% RDOR3 34.64 ▲ 0.64% HAPV3 11.28 ▲ 2.45% FLRY3 17.14 ▲ 1.00% SMTO3 14.52 ▲ 0.83% UGPA3 33.05 ▲ 0.39% VBBR3 36.05 ▲ 1.18% BBSE3 41.26 ▲ 0.98% BPAC11 56.80 ▲ 0.32% CURY3 30.09 ▼ 1.02% AERI3 2.15 ▲ 0.94% VIVARA 22.18 ▲ 0.09% COMPASS 24.84 — 0.00% VAMOS 3.34 ▼ 2.34% SANB11 28.62 ▲ 13.35% ASAI3 8.50 ▲ 1.07% SBSP3 27.70 ▲ 1.06% WALMEX 50.36 ▲ 0.34% GMEXICO 208.29 ▼ 2.20% FEMSA 221.95 ▲ 1.19% CEMEX 20.54 ▼ 0.73% GFNORTE 199.64 ▼ 0.32% BIMBO 62.08 ▲ 2.26% TELEVISA 9.79 ▼ 0.91% AMX 22.00 — 0.00% GAP 376.64 ▼ 1.08% ASUR 275.62 ▼ 0.34% OMA 231.05 ▼ 0.96% KOF 187.94 ▼ 0.14% GRUMA 258.23 ▼ 4.00% KIMBER 40.19 ▼ 0.17% SQM-B 62,700 ▼ 0.93% COPEC 6,350 ▲ 0.79% BSANTANDER 80.99 ▲ 0.36% FALABELLA 6,216 ▼ 0.06% ENELAM 87.99 ▲ 0.39% CENCOSUD 1,955 ▲ 0.51% CMPC 1,055 ▲ 2.43% BANCO CHILE 193.71 ▼ 1.57% LATAM AIR 24.74 ▼ 0.64% YPF 82,900 ▲ 1.94% GGAL 7,890 ▼ 1.56% PAMPA 5,555 ▲ 0.36% TXAR 659.50 ▲ 1.77% ALUAR 977.50 ▼ 0.20% TGS 10,050 ▲ 2.45% CEPU 2,396 ▼ 0.33% MIRGOR 16,350 ▼ 1.95% COME 44.03 ▼ 1.94% LOMA NEGRA 3,620 ▼ 1.76% BYMA 296.00 ▼ 0.34% TELECOM ARG 4,408 ▲ 2.14% ECOPETROL 16.77 ▼ 1.58% BANCOLOMBIA 92.52 ▼ 1.46% GRUPO AVAL 5.28 ▲ 2.75% CREDICORP 400.58 ▼ 0.42% SOUTHERN COPPER 182.71 ▼ 1.24% BUENAVENTURA 30.28 ▼ 4.96% MERCADOLIBRE 1,878 ▼ 0.41% NUBANK 14.33 ▼ 1.10% XP 17.06 ▼ 0.81% PAGSEGURO 9.64 ▼ 2.03% STONE 11.38 ▼ 0.48% GLOBANT 36.60 ▲ 0.58% TECNOGLASS 43.44 ▼ 0.34% GAP AIRPORT 217.35 ▼ 1.02% ASUR 275.62 ▼ 0.34% OMA AIRPORT 106.90 ▼ 1.10% AMX ADR 25.37 ▲ 0.18% FEMSA ADR 127.99 ▲ 0.97% CEMEX ADR 11.82 ▼ 0.92% PETROBRAS ADR 19.40 ▲ 1.46% VALE ADR 15.06 ▲ 0.47% ITAU ADR 8.46 ▲ 0.24% SANTANDER BR 5.67 ▲ 12.28% AMBEV ADR 3.11 ▼ 0.32% CSN 0.99 ▼ 2.42% GERDAU 4.96 — 0.00% LATAM ADR 52.75 ▼ 2.21% BTC 63,011 ▲ 0.39% ETH 1,854 ▲ 0.57% SOL 72.80 ▲ 1.30% XRP 1.08 ▲ 1.84% BNB 581.85 ▲ 1.20% ADA 0.19 ▲ 9.81% DOGE 0.07 ▲ 1.49% AVAX 6.58 ▲ 6.40% LINK 8.29 ▲ 2.90% DOT 0.80 ▲ 2.24% LTC 44.64 ▲ 1.03% BCH 212.20 ▲ 2.06% TRX 0.33 ▼ 0.34% XLM 0.17 ▲ 2.04% HBAR 0.07 ▲ 1.67% NEAR 1.70 ▲ 1.52% ATOM 1.25 ▲ 2.30% AAVE 91.00 ▲ 0.53% SELIC 14.25% EMBRAER 86.89 ▲ 0.87% EMBRAER ADR 68.33 ▲ 0.32% JBS 14.02 ▼ 1.89% JBS BDR 70.70 ▼ 2.01% MBRF3 17.54 ▼ 2.34% MBRFY 3.39 ▼ 2.31% INTER 5.60 ▼ 0.71%
since 2009
Sunday, August 2, 2026

Covid-19 Brazil

Herd Immunity Against Covid-19 May Not Exist, Suggests Chinese Study

By · June 19, 2020 · 3 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – Much is said about a near future in which humanity, through herd immunity, will no longer be susceptible to contracting certain viruses, such as Covid-19. In practice, theory works when a vaccine is developed. But for Chinese and American scientists, humans may never develop immunity against the novel coronavirus.

At least a quarter of the over 23,000 samples were infected with the virus, but only four percent developed antibodies by April - which does not mean they are immune.
At least a quarter of the over 23,000 samples were infected with the virus, but only four percent developed antibodies by April – which does not mean they are immune. (Photo: internet reproduction)
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →
RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →

The finding, which has not yet been peer-reviewed by members of the scientific community and is not even close to being published in a journal in the field, was based on a study that analyzed whether health professionals in Wuhan, China, pointed out as the virus’ source, had developed antibodies against the disease at the start of the pandemic.

At least a quarter of the over 23,000 samples were infected with the virus, but only four percent developed antibodies by April – which does not mean they are immune. Not very pleasant news amid the pandemic.

While for other diseases caused by a coronavirus, such as SARS and MERS, people developed antibodies capable of providing up to four years of immunity for those infected, it is unclear whether the same is true for Covid-19. Research shows that not everyone who was infected produced the necessary antibodies to stop future infections of the disease, and when they did, the immunities were not long lasting.

Almost six months after the outbreak of the pandemic, Wuhan decided to implement an unprecedented program to test the province’s entire 11 million population. By May 25th, some 6.8 million people had been tested and the initial results triggered an alert. The tests found 206 people with the virus active in their bodies. And despite being asymptomatic, they were spreading the disease.

Samples collected in March and April by Chinese researchers show that only ten percent of the population had developed antibodies to the virus. This indicates that without a vaccine, it will be even more challenging for everyone to develop an immunity to the disease simply by contracting it.

According to the researchers, antibody tests may not be enough to determine if someone has been infected, and just because they have them it doesn’t mean someone is necessarily immune. This further debunks the herd immunity theory and even antibody therapies for the treatment of Sars-CoV-2.

Another study by Tsinghua University in Beijing suggests that the more antibodies coronavirus patients produce, the worse the results – according to them, those with the strongest antibodies eventually died.

Yet other scientists urge caution and suggest that the study is not ironclad. The study was published on medrxiv.org.

To date, antibodies have been shown to be a good option for their capacity to neutralize the virus’ ability to infect cells in the human body. Once identified, they can be mass-produced – an approach that has already been successfully adopted in other cases, such as in treating the Ebola virus.

More than 130 vaccines are currently being produced against Covid-19. Some are in more advanced stages than others, such as the Coronavac by the Chinese company Sinovac, which is between stages one and two of production. According to Bloomberg news, over 90 percent of the people who received doses of the vaccine manufactured by the laboratory produced antibodies against Covid-19 within 14 days.

No therapy or vaccine has been clinically approved or endorsed by the World Health Organization to be specifically administered to patients infected with the novel coronavirus.

Source: Exame

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.